302 related articles for article (PubMed ID: 31521172)
1. Sialic acid metabolism as a potential therapeutic target of atherosclerosis.
Zhang C; Chen J; Liu Y; Xu D
Lipids Health Dis; 2019 Sep; 18(1):173. PubMed ID: 31521172
[TBL] [Abstract][Full Text] [Related]
2. Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein.
Tertov VV; Kaplun VV; Sobenin IA; Boytsova EY; Bovin NV; Orekhov AN
Atherosclerosis; 2001 Nov; 159(1):103-15. PubMed ID: 11689212
[TBL] [Abstract][Full Text] [Related]
3. A Pasteurella multocida sialyltransferase displaying dual trans-sialidase activities for production of 3'-sialyl and 6'-sialyl glycans.
Guo Y; Jers C; Meyer AS; Arnous A; Li H; Kirpekar F; Mikkelsen JD
J Biotechnol; 2014 Jan; 170():60-7. PubMed ID: 24291191
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of the sialidase and trans-sialidase activities of bacterial sialyltransferases from glycosyltransferase family 80.
Mehr K; Withers SG
Glycobiology; 2016 Apr; 26(4):353-9. PubMed ID: 26582604
[TBL] [Abstract][Full Text] [Related]
5. Trans-sialidase Associated with Atherosclerosis: Defining the Identity of a Key Enzyme Involved in the Pathology.
Glanz VY; Myasoedova VA; Grechko AV; Orekhov AN
Curr Drug Targets; 2019; 20(9):938-941. PubMed ID: 30848200
[TBL] [Abstract][Full Text] [Related]
6. Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments.
Gianchecchi E; Arena A; Fierabracci A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071314
[TBL] [Abstract][Full Text] [Related]
7. Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation.
Naito Y; Takematsu H; Koyama S; Miyake S; Yamamoto H; Fujinawa R; Sugai M; Okuno Y; Tsujimoto G; Yamaji T; Hashimoto Y; Itohara S; Kawasaki T; Suzuki A; Kozutsumi Y
Mol Cell Biol; 2007 Apr; 27(8):3008-22. PubMed ID: 17296732
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein sialylation in atherosclerosis: Lessons from mice.
Yu L; Peng J; Mineo C
Front Endocrinol (Lausanne); 2022; 13():953165. PubMed ID: 36157440
[TBL] [Abstract][Full Text] [Related]
9. Sialylation: an Avenue to Target Cancer Cells.
Vajaria BN; Patel KR; Begum R; Patel PS
Pathol Oncol Res; 2016 Jul; 22(3):443-7. PubMed ID: 26685886
[TBL] [Abstract][Full Text] [Related]
10. Diagnostics and Therapy of Human Diseases - Focus on Sialidases.
Karagodin VP; Sukhorukov VN; Myasoedova VA; Grechko AV; Orekhov AN
Curr Pharm Des; 2018; 24(24):2870-2875. PubMed ID: 30198428
[TBL] [Abstract][Full Text] [Related]
11. Tools to study and target the Siglec-sialic acid axis in cancer.
Läubli H; Kawanishi K; George Vazhappilly C; Matar R; Merheb M; Sarwar Siddiqui S
FEBS J; 2021 Nov; 288(21):6206-6225. PubMed ID: 33251699
[TBL] [Abstract][Full Text] [Related]
12. Non-canonical roles of Siglecs: Beyond sialic acid-binding and immune cell modulation.
Siddiqui SS
Mol Aspects Med; 2023 Apr; 90():101145. PubMed ID: 36153172
[TBL] [Abstract][Full Text] [Related]
13. Preliminary 1H NMR investigation of sialic acid transfer by the trans-sialidase from Trypanosoma cruzi.
Wilson JC; Kiefel MJ; Albouz-Abo S; von Itzstein M
Bioorg Med Chem Lett; 2000 Dec; 10(24):2791-4. PubMed ID: 11133093
[TBL] [Abstract][Full Text] [Related]
14. Sialidases: Therapeutic and Antiatherogenic Potential.
Sukhorukov VN; Karagodin VP; Zakiev ER; Grechko AV; Orekhov AN
Curr Pharm Des; 2017; 23(31):4696-4701. PubMed ID: 28911304
[TBL] [Abstract][Full Text] [Related]
15. Sialyltransferase inhibition and recent advances.
Wang L; Liu Y; Wu L; Sun XL
Biochim Biophys Acta; 2016 Jan; 1864(1):143-53. PubMed ID: 26192491
[TBL] [Abstract][Full Text] [Related]
16. The expression of sialyltransferases is regulated by the bioavailability and biosynthesis of sialic acids.
Bork K; Weidemann W; Berneck B; Kuchta M; Bennmann D; Thate A; Huber O; Gnanapragassam VS; Horstkorte R
Gene Expr Patterns; 2017 Jan; 23-24():52-58. PubMed ID: 28351515
[TBL] [Abstract][Full Text] [Related]
17. Dual actions of group B
Uchiyama S; Sun J; Fukahori K; Ando N; Wu M; Schwarz F; Siddiqui SS; Varki A; Marth JD; Nizet V
Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7465-7470. PubMed ID: 30910970
[TBL] [Abstract][Full Text] [Related]
18. Modulating the regioselectivity of a Pasteurella multocida sialyltransferase for biocatalytic production of 3'- and 6'-sialyllactose.
Guo Y; Jers C; Meyer AS; Li H; Kirpekar F; Mikkelsen JD
Enzyme Microb Technol; 2015 Oct; 78():54-62. PubMed ID: 26215345
[TBL] [Abstract][Full Text] [Related]
19. The sialylation of plasma lipoproteins.
Millar JS
Atherosclerosis; 2001 Jan; 154(1):1-13. PubMed ID: 11137077
[TBL] [Abstract][Full Text] [Related]
20. Sialidase substrates for Sialdiase assays - activity, specificity, quantification and inhibition.
Yuan L; Zhao Y; Sun XL
Glycoconj J; 2020 Oct; 37(5):513-531. PubMed ID: 32813176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
